ALTE07C1, Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer

Study ID
STU 012011-037

Cancer Related

Healthy Volunteers

Study Sites

  • UT Southwestern-Other
  • Children’s Medical Center (Dallas, Plano, Southlake)

Ryan Carstens

Principal Investigator
Patrick Leavey


The aLTe07C1 standard neuropsychological and behavioral battery of tests will take only 1 to 2 hours to administer and all patients will be tested at 3 standardized timepoints. Parent-completed questionnaires will also be utilized to gather information about the patient's function, specifically in terms of attention, memory, executive abilities, and behavioral/social/emotional adaptation.

aLTe07C1 is not a complete evaluation of a child's intelligence or school achievement; rather, it is a brief set of assessments used for research to determine effects of the treatment and to find out if using a standard set of neuropsychological and behavioral tests, such as the testing in aLTe07C1, can be consistently completed at all the CoG hospitals and at 3 standard timepoints.

Participant Eligibility

The patient must be currently be enrolled or plan to be enrolled on a COG therapeutic study that aims to examine neuropsychological, social, emotional, and/or behavioral functioning. The patient must have receptive and expressive language skills in English since the assessment instruments are standardized and validated among English-speakers. All patients and/or their parents or legal guardians must sign a written informed consent. All institutional, FDA, and NCI requirements for human studies must be met.